Aldeyra Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ALDX and other ETFs, options, and stocks.

About ALDX

Aldeyra Therapeutics, Inc. is a biotechnology company, which engages in research and development activities related to general business planning, including raising capital. It focuses on the discovery of therapies designed to treat immune-mediated diseases. 

CEO
Todd C. Brady
CEOTodd C. Brady
Employees
8
Employees8
Headquarters
Lexington, Massachusetts
HeadquartersLexington, Massachusetts
Founded
2004
Founded2004
Employees
8
Employees8

ALDX Key Statistics

Market cap
106.77M
Market cap106.77M
Price-Earnings ratio
-3.87
Price-Earnings ratio-3.87
Dividend yield
Dividend yield
Average volume
1.15M
Average volume1.15M
High today
$1.78
High today$1.78
Low today
$1.70
Low today$1.70
Open price
$1.71
Open price$1.71
Volume
831.67K
Volume831.67K
52 Week high
$6.18
52 Week high$6.18
52 Week low
$1.07
52 Week low$1.07

Stock Snapshot

Aldeyra Therapeutics(ALDX) stock is priced at $1.73, giving the company a market capitalization of 106.77M. It carries a P/E multiple of -3.87.

On 2026-06-12, Aldeyra Therapeutics(ALDX) stock traded between a low of $1.70 and a high of $1.78. Shares are currently priced at $1.73, which is +2.1% above the low and -2.5% below the high.

Aldeyra Therapeutics(ALDX) shares are trading with a volume of 831.67K, against a daily average of 1.15M.

During the past year, Aldeyra Therapeutics(ALDX) stock moved between $1.07 at its lowest and $6.18 at its peak.

During the past year, Aldeyra Therapeutics(ALDX) stock moved between $1.07 at its lowest and $6.18 at its peak.

ALDX News

Simply Wall St 3d
Aldeyra Therapeutics CEO, President & Director Acquires 18% More Stock

Investors who take an interest in Aldeyra Therapeutics, Inc. ( ) should definitely note that the CEO, President & Director, Todd Brady, recently paid US$1.67 pe...

Aldeyra Therapeutics CEO, President & Director Acquires 18% More Stock
TipRanks 3d
Aldeyra Therapeutics Adds Independent Director, Affirms Governance Support

The latest update is out from Aldeyra Therapeutics ( (ALDX) ). On June 9, 2026, following its annual meeting of stockholders, Aldeyra Therapeutics appointed ve...

People also own

Based on the portfolios of people who own ALDX. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.